New eye drop study targets Early-Stage dry eye
NCT ID NCT06981104
Summary
This study tested whether a medication called cyclosporine, delivered as eye drops, could help people with mild to moderate dry eye. Researchers compared it to standard artificial tear therapy in 60 participants to see if it was better at controlling the condition and safe to use. The goal was to see if treating the inflammation early with this medication could break the cycle of dry eye symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
1 Xihu Avenue, Shangcheng District, Hangzhou, Zhejiang, China
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.